Researchers link death in gene-editing study to a virus used to deliver the treatment, not CRISPR

The lone volunteer in a gene-editing study targeting a rare form of Duchenne muscular dystrophy most likely died after having a reaction to the virus that delivered the therapy in his body. …

Related Keywords

Connecticut ,United States ,Montour Falls ,New York ,New York University ,Yale University ,Terence Flotte ,Terry Horgan ,Arthur Caplan ,Jesse Gelsinger ,York University ,Science Department ,Educational Media Group ,University Of Massachusetts Chan Medical School ,Howard Hughes Medical Institute Science ,Drug Administration ,Nobel Prize ,Cure Rare Disease ,Rich Horgan ,Massachusetts Chan Medical School ,Cure Rare ,Associated Press Health ,Howard Hughes Medical Institute ,Educational Media ,